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Abstract: Mitochondria harbor their own genetic system, yet critically depend on the import of a
number of nuclear-encoded macromolecules to ensure their expression. In all eukaryotes, selected
non-coding RNAs produced from the nuclear genome are partially redirected into the mitochondria,
where they participate in gene expression. Therefore, the mitochondrial RNome represents an
intricate mixture of the intrinsic transcriptome and the extrinsic RNA importome. In this review,
we summarize and critically analyze data on the nuclear-encoded transcripts detected in human
mitochondria and outline the proposed molecular mechanisms of their mitochondrial import. Special
attention is given to the various experimental approaches used to study the mitochondrial RNome,
including some recently developed genome-wide and in situ techniques.
Keywords: mitochondria; RNA import; PNPase; RNA importome landscaping; microscopy
1. Introduction
Mitochondria possess their own genome (mtDNA), which, in humans, encodes 11 mRNAs,
2 ribosomal, and 22 transfer RNAs required for the synthesis of 13 proteins of the oxidative
phosphorylation complexes (Figure 1). However, this is far from being sufficient to perform all
their functions, which necessitate more than 1000 proteins encoded by the nuclear DNA, synthetized
in the cytosol and imported into mitochondria [1]. These include structural components, enzymes,
and all the protein factors required for the maintenance and expression of the small mitochondrial
genome. Additionally, in all groups of eukaryotes, some non-coding RNAs have been predicted
or experimentally demonstrated to translocate into the mitochondria; this import pathway is often
essential for the mitochondrial function [2–4]. In many cases, this is to be expected: the absence of an
RNA gene whose product is strictly required for mitochondrial translation from the mitochondrial
genome is usually considered a strong indication for the existence of a compensatory mitochondrial
RNA import pathway. Indeed, in some species, tRNAs for select amino acids are not encoded
in mtDNA and must be imported from the cytosol, ranging from just a few tRNAs in plants
to the complete tRNA set in such protists as Trypanosoma brucei [5] and Leishmania tarentolae [6].
However, even in species in which all required tRNAs are encoded by the mitochondrial genome,
tRNA import from the cytosol has been observed and is likely to become essential under particular
stress conditions. This is notably the case of tRNALysCUU (tRK1) in baker yeast S. cerevisiae [7,8].
The partial import of other cytosolic non-coding RNAs (including miRNAs and lncRNAs) has beens
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similarly reported in mammals, albeit their role inside the mitochondrial compartment is far from
being obvious [9–11]. Such cases of seemingly superfluous targeting of nuclear-encoded RNAs into
mitochondria beg the question of their functional significance and the mechanisms of their transport
into the organelles. On the other hand, much of what we know about the RNA import phenomenon
critically depends on the robustness of the analysis techniques employed to discover and characterize
imported RNAs. Recent methodological developments relying on ingenuously tailored in situ and
interactomic approaches promise to shed light on many of these questions.
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Select tRNAs
(including
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tRNAGlnCUG)
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Table 1. Cont.
RNA CytosolicFunction
Evidence for Mitochondrial
Localisation
Proposed
Function in
Mitochondria
References
5S rRNA Component of thecytosolic ribosome
• Deep sequencing of RNA isolated
from mitoplasts
• RT-(q)PCR of RNA isolated
from mitoplasts
• Northern blotting of RNA isolated
from mitoplasts
• Enrichment in mitoplasts in
comparison to crude mitochondria
• Import into isolated mitochondria
• Fluorescence microscopy (aptamer
tagging, direct labeling)
Related to
mitochondrial
translation?
[11–16]
H1 RNA
Component of the
nuclear RNase P
required for
pre-tRNA
processing
• Deep sequencing of RNA isolated
from mitoplasts
• RT-(q)PCR of RNA isolated
from mitoplasts
• Enrichment in mitoplasts in
comparison to crude mitochondria
• Import into isolated mitochondria
Pre-tRNA
processing? [11,17–19]
RMRP 5.8S rRNAprocessing
• Deep sequencing of RNA isolated
from mitoplasts
• RT-(q)PCR of RNA isolated
from mitoplasts
• Enrichment in mitoplasts in
comparison to crude mitochondria
• Import into isolated mitochondria
• Electron microscopy
Mitochondrial
RNA
metabolism?
[11,19–22]
SAMMSON
Facilitates p32
targeting to the
mitochondria in
melanoma cells
• RT-qPCR of RNA isolated
from mitoplasts
• Fluorescence microscopy (FISH)
Unknown [23,24]
hTERC RNA component oftelomerase
• RT-PCR of RNA isolated
from mitoplasts
• Import into isolated mitochondria
Mitochondria-
cytosol
communication
[25]
Various miRNAs
(including miR-1,
miR-181c,
miR-378) and
pre-miRNAs
Repression of
mRNA translation
• Deep sequencing of RNA isolated
from mitoplasts
• RT-qPCR of RNA isolated
from mitoplasts
• Enrichment in mitoplasts in
comparison to crude mitochondria
• Fluorescence microscopy (FISH)
Repression or
activation of
mRNA
translation,
repression of
transcription
[11,26–34]
2. Mitochondrial RNA Importome
The nuclear-encoded transcripts so-far detected in the human mitochondria are extremely diverse
in size, structure, and primary function. However, all of them are non-coding RNAs, suggesting that
the nucleus normally does not supply the mitochondrial genetic system with messenger RNAs, and all
the polypeptides translated on the mitochondrial ribosomes are of strictly mitochondrial origin [11].
This situation actually seems to be common to all mitochondria and plastids, limiting the RNA import
pathway to a bunch of usually small non-coding RNA species [2–4].
2.1. tRNAs
Human mtDNA encodes 22 tRNAs, which represents, taking into account the peculiarities of
the mammalian mitochondrial genetic code, the minimal tRNA set sufficient for the translation of all
mitochondrial mRNAs [35]. Surprisingly, however, some fully processed and apparently modified
nuclear-encoded tRNAs have been detected inside the organelles by deep sequencing of RNA isolated
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from purified, RNase-treated mitoplasts (mitochondria devoid of the outer membrane) [11]. Some
of them (e.g., tRNALeuUAA and tRNAGlnUUG) were enriched in comparison to crude mitochondria,
further supporting their identification as potentially imported species. Although the authors have not
provided a complete list of the enriched tRNAs, this study rose the questions of whether mammalian
mitochondria can eventually obtain some tRNAs from the cytosol and whether those could be involved
in mitochondrial translation.
Indeed, tRNAGlnCUG and tRNAGlnUUG were detected inside both rat and human mitochondria
by RT-PCR, and the generic ability of isolated human mitochondria to internalize extraneous tRNA
molecules of diverse origin in vitro has been demonstrated [9,10]. It was hypothesized that the import
of cytosolic tRNAGln could support efficient mitochondrial translation in the case where the wobble
position of the mitochondrial tRNAGln is not correctly modified and decoding of GAG codons becomes
compromised, a mechanism similar to the one described in yeast [8]. However, such conditions
and their corresponding adaptive mechanism in humans, if any, remain to be identified. Moreover,
unlike the cytosolic compartment, where Gln-tRNAGln is obtained via direct glutaminylation by
glutamine-tRNA synthetase (QARS), mitochondria use the indirect transamidation pathway, where
tRNAGln is first misaminoacylated by the mitochondrial glutamyl-tRNA synthetase (mtEARS) and
then converted into Gln-tRNAGln by the GatCAB complex [36]. Taking into account that human
mitochondria lack QARS, and the GatCAB activity is required for mitochondrial translation [37], while
the cytosolic tRNAGln is a poor substrated for GatCAB [36], it seems unlikely that imported tRNAGln
may significantly contribute to the mitochondrial protein synthesis.
The ability of human mitochondria to import heterologous tRNAs in vivo has also been
extensively studied. For instance, the yeast tRNALysCUU (tRK1), one of the two nuclear-encoded
tRNAsLys, is partially redirected to mitochondria [7]. Although yeast mitochondria already encode
a tRNALys (tRK3) capable to decode both lysine codons, the wobble uridine of the tRK3 anticodon
has a 2-thio modification, which cannot be efficiently formed at 37 ◦C, leading to a codon recognition
defect under heat shock conditions. Thus, the import of tRK1, although dispensable at 30 ◦C, becomes
essential for the translation of AAG codons at 37 ◦C [8]. Interestingly, when artificially expressed
in human cells, tRK1 was similarly found to be imported into mitochondria [38]. Moreover, several
tRK1-inspired transfer RNAs with altered amino acid identities retained the ability to go into the
human mitochondria and could rescue mitochondrial mutations in cognate tRNA genes [38–40].
While this model is clearly artificial, it shows that at least a cryptic tRNA import pathway may exist in
human cells and be exploited for therapeutic purposes.
2.2. 5S rRNA
5S ribosomal RNA (5S rRNA) is a component of the large subunit of most ribosomes, absent only
in some mitochondria [41]. Located in the central protuberance, it acts as a scaffold interconnecting
several functionally important sites on the ribosome [42–44]. No 5S rRNA homologue is encoded
in the mammalian mitochondrial genome, but the nuclear-encoded 5S rRNA has been found in
abundance in mammalian mitochondria by several teams [11–15]. For a long time, it was believed
that 5S rRNA was incorporated in the mitochondrial ribosome. However, recent studies showed that
mammalian mitochondrial ribosomes do not contain stably integrated 5S rRNA and instead harbor a
mitochondria-encoded tRNA [45–47], leaving the mitochondrial function of 5S rRNA open to question.
Interestingly, the knockdown of any of the three protein factors required for the 5S rRNA import in
humans has led to a decrease of the mitochondrial translation and compromised the ability of cells to
grow in the absence of glucose [19,48,49], an effect that cannot be always explained by other known
functions of these proteins. This hints at a so-far unknown function of 5S rRNA in the mitochondrial
protein synthesis that may involve the regulation of mitochondrial translation or the assembly of
mitochondrial ribosomes.
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2.3. RNase P RNA Component (H1 RNA)
RNase P is found in nearly all living organisms where its main function is to remove the 5′
leader sequence from tRNA precursors. This activity is critical for the processing of mitochondrial
polycistronic transcripts according to the tRNA punctuation model [50,51]. Two types of RNase
P have been found in different organisms: RNase P ribonucleoproteins, composed of a catalytic
RNA component (H1 RNA) associated with one or several proteins, and protein-only RNases P
(PRORP) [52,53]. For example, nuclear RNase P in humans and yeast is a ribonucleoprotein, a situation
typical for opistokonts. On the contrary, although in some species mitochondrial RNase P contains
both an RNA and protein subunits (and in many fungi the RNase P RNA component can even be
encoded in mtDNA), in the majority of cases, mitochondria rely on nuclear-encoded PRORP enzymes
to process their tRNAs [53]. This is also the case in the human mitochondria, where the RNase P activity
is provided by a well-studied protein-only complex composed of three subunits [54]. Nevertheless,
a ~340-nt transcript corresponding to the nuclear H1 RNA has also been detected in mitochondria
and suggested to participate in mitochondrial tRNA processing [11,17–19]. Although some bacteria
and archaea, indeed, have both a RNA-based and a protein-only RNases P [55], such a situation
appears to be unique among mitochondria. Of note, to date there is no evidence that a functional
RNase P ribonucleoprotein can be assembled inside human mitochondria (since the H1 RNA-binding
proteins are normally localized in the nucleus), arguing against the role of the imported H1 RNA in
mitochondrial RNA processing.
2.4. RNase MRP RNA Component (RMRP)
In the nucleus, the catalytic RNA component of mitochondrial RNA processing (MRP)
ribonuclease (also known as RMRP), which is evolutionarily related to the H1 RNA [56], is involved
in the 5′ end maturation of 5.8S rRNA [57]. RMRP has also been reported to play a role in the cell
cycle regulation [58] and to associate with the telomerase reverse transcriptase (TERT) for the synthesis
of double-stranded RNA further processed into short interfering RNAs [59]. While RMRP mainly
localizes in the nucleus, a small part of its pool has been found in mammalian mitochondria [22].
Its possible function was initially studied in isolated mouse mitochondria, where it was supposed
shown to process the RNA primer for the replication of the mtDNA heavy strand [20,60]. However,
recent studies have shown that the RNA primer formation is a consequence of a premature arrest of the
mitochondrial RNA polymerase after a G-quadruplex situated in the control region of human mtDNA,
which takes place when RNA polymerase is not associated with the transcription elongation factor
TEFM [61]. Moreover, it was demonstrated that only the 3′ half (~130 nt) of RMRP can be found inside
mitochondria, the RNA being processed upon or during the mitochondrial import [20,21]. Given the
specific pseudoknotted structure of RMRP, which is required for its function, this cleavage would
normally result in a loss of catalytic activity [56]. Therefore, it is unlikely that RMRP acts as a nuclease
in the mitochondrial compartment. However, a recent study has shown that human RMRP interacts
with GRSF1, an important component of mitochondrial RNA granules [62,63], suggesting that it may
still be involved in mitochondrial RNA metabolism.
2.5. SAMMSON
SAMMSON is a lncRNA that is predominantly expressed in aggressive melanomas, where
it is required to stimulate the mitochondrial function of actively proliferating tumor cells [23,24].
SAMMSON localizes in the cytoplasm and is proposed to interact with the protein p32, another
pro-oncogenic factor involved in the regulation of mitochondrial gene expression [64,65]. Knockdown
of SAMMSON impairs the p32 targeting to the mitochondria, whose activity is essential for quickly
dividing melanoma cells and results in a mitochondrial protein synthesis defect. Because SAMMSON
was found to colocalize and copurify with mitochondria, it was suggested that its involvement in p32
traffic could be accompanied by its own mitochondrial import [23], which still needs to be confirmed
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with alternative approaches. Importantly, both SAMMSON and its role in p32 transport are likely
specific to melanoma cells, since in a variety of other models p32 does not seem to require special
factors for efficient import into the mitochondria [66–68].
2.6. hTERC
Recently, the RNA component of the human telomerase, hTERC, encoding the sequence of the
simple repeats added to the ends of DNA (telomere) [69], has also been proposed to be imported into
mitochondria [25]. In this study, the import of hTERC was initially suspected based on the presence
of a region similar to a short stem-loop that, in H1 RNA and RMRP, facilitates the mitochondrial
localization of RNAs (see Figure 3c below) [19]. Indeed, the presence of hTERC in purified mitoplasts
treated with micrococcal nuclease was confirmed by RT-PCR. Surprisingly, deletion of this sequence
from hTERC significantly increased its mitochondrial import instead of abolishing it. Similarly to
RMRP, hTERC was found to be processed upon mitochondrial import into a shorter 195 nt-long RNA
termed TERC-53. Since the processed version of hTERC was detected mostly in the cytosol, the authors
suggested that TERC-53 is re-exported from the mitochondria, which would permit to somehow
relay the functional state of the mitochondria to the nucleus and other cellular compartments [25,70].
However, evidence that hTERC processing occurs within the mitochondrial matrix and not at the
mitochondrial surface is currently lacking.
2.7. microRNAs
miRNAs are non-coding RNA molecules of about 22 nucleotides that target and repress mRNAs
at a level of stability and/or translation through the recruitment of the RNA-induced silencing complex
(RISC) [71,72]. They are transcribed as primary microRNAs (pri-miRNAs), which are processed in the
nucleus by the DROSHA/DGCR8 complex into precursor (pre)microRNAs, exported to the cytoplasm
and further cleaved by DICER1 into mature miRNAs. Then, they associate with the RNA-binding
protein Argonaute 2 (AGO2), a component of RISC, and bring the complex to the target mRNA, usually
by annealing to a specific region in the 3′ UTR.
Pioneered with RT-qPCR- and microscopy-based analyses and more recently powered by deep
sequencing, the discovery of miRNAs localized in mammalian mitochondria has soared over the last
decade [11,27,28,31–33]. While most mitochondrial miRNAs seem to be nuclear-encoded and imported
inside the mitochondria or associated with the outer mitochondrial membrane, a few miRNAs have
been suggested to be produced by mtDNA itself [27,28,31,73–75]. An in silico analysis has revealed
multiple putative miRNA-binding sites on the mitochondrial DNA [27]. However, the possible mode
of action of microRNAs in the mitochondrial compartment is unclear, since mitochondrial mRNAs
contain no or small 3′ UTRs, and only one component of RISC—AGO2—has been proposed to localize
to the mitochondrial matrix [26,30,31]. Indeed, some mitochondria-localized miRNAs have been found
to enhance the synthesis of select mitochondrial proteins instead of inhibiting it. For example, miR-1 is
able to stimulate the translation of MT-ND1 and MT-CO1 mRNAs in an AGO2-dependent manner,
while repressing some nuclear DNA-encoded mRNA targets in the cytosol, both pathways being
important for muscle differentiation in mouse [30]. On the contrary, miR-181c has been suggested
to repress the expression of MT-CO1 in rat heart by targeting its 3′ UTR [29,76], and miR-378 has
been found to downregulate MT-ATP6 in mouse HL-1 cells [77]. Other non-canonical functions
of mitochondrial miRNAs can be expected, and many hypotheses have been proposed, including
targeting mitochondrial transcription in human [34]. However, a convincing demonstration of the
corresponding molecular mechanisms is notoriously difficult, given that miRNAs may affect the
expression of nuclear genes involved in mitochondrial biogenesis and function, and ruling out such
indirect effects caused by their canonical action in the cytosol is anything but easy.
Besides its role in regulation of mitochondrial gene expression, it has been suggested that imported
miRNAs may undergo post-transcriptional modification in the mitochondria or on their surface,
leading to structural changes and adjustment in their RNA and/or protein interaction specificities,
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before being released back to the cytosol [26,78]. It is also important to keep in mind that the sets
of mitochondria-associated miRNAs found in various cell types show a remarkably poor overlap:
in human, only seven miRNAs have been identified in at least three different studies, and most
mitochondrial miRNAs have only been reported in one or two studies [26]. Such low reproducibility,
although partially imputable to cell type variations, raises urgent questions with regard to the
methodology used to identify and validate potentially imported miRNA species.
3. Mechanisms of RNA Import
3.1. RNA Targeting to the Mitochondria in Various Eukaryotes
Although the mitochondrial RNA import is ubiquitously found among eukaryotes, the
mechanisms that direct mitochondrial targeting and transfer of RNAs into the mitochondrial matrix
seem to differ greatly between organisms (Figure 2) [2,79,80]. In general, mitochondrial RNA import
involves three criteria: (1) the presence of selective signals, or import determinants, within the
imported RNA; (2) a mechanism to intercept RNA from its cytosolic location and redirect it to the
mitochondrial surface; and (3) a translocation pathway to transfer the RNA molecule across the
mitochondrial envelope.Cells 2019, 8, x FOR PEER REVIEW 8 of 27 
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Figure 2. RNA import mechanisms in various eukaryotic models. (a) In plants, the targeting of RNA to
mitochondria probably relies on some unidentified cytosolic factors (e.g., aminoacyl-tRNA synthetases).
Translocation across the outer mitochondrial membrane (OMM) requires Tom20, Tom40, involved
in the pre-protein import, as well as the voltage-dependent anion channel (VDAC). The mechanism
of translocation across the inner mitochondrial membrane (IMM) remains unknown. (b) In T. brucei,
tRNAs are directed to the mitochondrial import by the translation elongation factor eEF1α, while the
archaic translocase of the outer membrane (ATOM), which also transports mitochondrial pre-proteins,
mediates their translocation though OMM. (c) Mitochondrial RNA import in S. cerevisiae and humans.
RNAs are targeted to mitochondria by various nuclear-encoded proteins normally localized inside or
in the vicinity of mitochondria. In S. cerevisiae, translocation into the mitochondrial matrix is mediated
by the protein import machinery (translocases of the outer and inner membranes, TOM, and TIM).
In humans, the translocation mechanism is unknown but seems to require the protein PNPase located
in the intermembrane space. ∆Ψ: membrane potential.
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Mechanisms of RNA import into plant mitochondria remain elusive (Figure 2a). Generally, only a
few cytosolic tRNAs translocate into the mitochondria to replace their missing counterparts. In vitro
import tests have suggested that the tRNA import did not require cytosolic factors; however, mutations
disrupting aminoacylation of tRNAs prevented their import in vivo, and addition of protein factors
improved tRNA import rates in vitro. This indicates the potential involvement of aminoacyl-tRNA
synthetases as carrier proteins to direct tRNA to plant mitochondria [79,81], although other unidentified
factors may also participate in this process. The mitochondrial tRNA transport across the membranes
is ATP-dependent and requires the presence of the membrane potential [82]. VDAC (porin) has been
identified as the main channel for translocation of tRNAs across the outer mitochondrial membrane in
potato, with the participation of complexes of the protein import machinery (Tom20 and Tom40) [83,84].
However, the mechanism of translocation through the inner membrane remains unknown.
The pervasive mitochondrial tRNA targeting in the kinetoplastid T. brucei (Figure 2b) seems to
be specified by a signal in the T-loop of tRNAs recognized by the cytosolic elongation factor eEF1α,
thus only excluding tRNAMeti, which does not bind eEF1α, from this pathway [85]. The translocation
into the mitochondrial matrix is also ATP-dependent and occurs through the protein import apparatus
ATOM (archaic translocase of the outer membrane) complex [86,87].
3.2. Mitochondrial RNA Targeting in Yeast and Human
Interestingly, the yeast and human RNA import pathways seem to share several features
(Figure 2c). In both cases, interplay of specific mitochondria-related cytosolic proteins is required
to intercept the imported RNA from its primary location and redirect it toward the mitochondria,
followed by translocation, which at least partially depends on the pre-protein import apparatus.
In yeast, the glycolytic enzyme enolase (Eno2p), probably helped by some additional cytosolic factors,
first interacts with tRK1 and brings it to the mitochondrial surface [88]. Interaction of Eno2p with tRK1
induces a conformational change of the tRNA so that the 3′ extremity of the tRNA folds back on the
3′ side of the T-arm to form the so-called F-stem-loop (Figure 3a) [89–91]. This rearrangement also
involves the anticodon arm and the variable region, while the D-arm remains intact. This alternative
tRK1 structure has an improved affinity to the second protein factor, precursor of the mitochondrial
lysyl-tRNA synthetase (preMSK), which mediates the tRK1 transport to the mitochondrial matrix.
Interestingly, the F- and D-stem-loops grafted on heterologous transcripts were sufficient to induce
mitochondrial import of small synthetic RNAs in vivo [90]. Of note, since both enolase and the
mitochondrial lysyl-tRNA synthetase are also present in human cells, they could sustain the import
of exogenously introduced tRK1 into human mitochondria [92,93]. Import of tRK1 and its synthetic
derivatives bearing the F- and D-stem-loops have been used to mitigate the consequences of some
pathogenic mutations in mtDNA [39,94].
The 5S rRNA import in human mitochondria follows a similar logic (Figure 2c) [95]. 5S rRNA
is transcribed by RNA polymerase III with the help of the transcription factor IIIA (TFIIIA) and is
exported to the cytosol in complex with TFIIIA, where it interacts, through its β-domain, with the
cytosolic ribosomal protein L5 (Figure 3b) [96]. 5S rRNA is then imported back to the nucleus to
be incorporated in nascent cytosolic ribosomes. In the cytosol, 5S rRNA can alternatively interact,
through its γ-domain, with the precursor of the mitochondrial ribosomal protein L18 (MRP-L18, or
its recently described cytosolic isoform [97]) and be redirected to the mitochondria [49]. Similarly to
tRK1 and enolase, the interaction with MRP-L18 induces a change in the conformation of the 5S rRNA
molecule and allows for the interaction of its α-domain with the second protein factor, rhodanese,
and subsequent import of the RNA-protein complex into the mitochondrial matrix [15,48]. Both α-
and γ-domains are essential for mitochondrial targeting of 5S rRNA, whereas the β-domain is only
involved in 5S rRNA incorporation in the cytosolic ribosome. Not surprisingly, the removal of the
β-domain or its substitution with a short RNA sequence does not alter the import of 5S rRNA and
may even increase its targeting to mitochondria [95].
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upon binding with enolase. ′ t i teracts ith the 3′ side of the T-arm to
form a new F-stem-loop whic , together with the D-arm, functions as a import determinant. Adapted
from [93]. (b) The secondary tructure and major functional sites of human 5S rRNA. Interactions
with the precursor of th mit chondrial ribosomal protein MRP-L18 and with the enzyme rhodanese
(sites highligh d in blue) specify th 5S rRNA impo t into itocho dria. Adapted from [95]. (c) The
stem-loop structures proposed to act as p lynucleotide ph sphorylase (PNPase)-binding import
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The mechanisms f mitocho drial targeting f other RNAs are much less studied but may
similarly involve some protein factors destin d for the mitochondrial matrix. For example, a recent
study showed that, in humans, the RMRP export from the ucleus is mediated by the protein HuR
and, once in the itoch ndria, this RNA interacts with GRSF1 [21]. One of the tw proteins may also
be res nsible for the targeting of RMRP to the mi ochondrial surface. Similarly, the main candidate
for the m ochondrial targe ing of mammalian iRNAs remains AGO2, also detected inside the
organelles [30]. Finally, one cannot exclude that some protein factors required fo mRNA localizati n
on the mitochondrial surface [98,99] may be recruited to bring along select n n-coding RNAs. Further
studi s are required to verify these hypotheses.
3.3. Translocation through the Mitochondrial Membranes and the Role of Pnpase
Mechanisms of RNA translocation across the mitochondrial membranes in humans are not
well understood. It has been shown that the process is ATP-dependent, requires the presence of
the membrane potential, and might involve the protein import apparatus, as has been observed in
yeast [14,100]. The RNA translocation through the outer mitochondrial membrane (OMM) may be
mediated by the TOM complex and/or VDAC channel (our unpublished results).
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Much more is known about the possible mechanism of RNA translocation through the
intermembrane space (IMS) involving polynucleotide phosphorylase (PNPase, Figures 2c and 4) [19].
PNPase is an evolutionarily conserved 3′ -to-5′ exoribonuclease encoded in human by the PNPT1
gene. It possesses an N-terminal signal for mitochondrial localization and has been detected in both
the mitochondrial matrix and IMS [101,102]. In the matrix, PNPase, in complex with the DNA/RNA
helicase SUV3, is involved in general RNA decay, MT-ND6 mRNA processing, non-coding RNA
clearance, and R-loop resolution [103–107]. In IMS, it is believed to be a factor in RNA import in
the mitochondria [19], to control the escape of mitochondrial double-stranded RNA into the cytosol
under physiological and disease conditions [108], and may, upon release into the cytosol, also play a
role in apoptosis [109]. Mutations in human PNPase are linked to mitochondrial diseases of varying
severities, characterized by respiratory chain deficiencies and associated with both mitochondrial RNA
processing defects and perturbed RNA import [110–113]. Given the pervasive impact of PNPase on
the mitochondrial RNA metabolism, it is not always possible to disentangle the observed phenotypes
and conclusively connect them with various functions proposed for this protein.
Since PNPase is a nuclease, the mechanism by which it could be involved in RNA import remains
puzzling, although bacterial PNPase homologues are known to eventually act as simple RNA-binding
proteins without degrading their associated transcripts (reviewed in [114]). It was postulated that
PNPase can recognize stem-loop structures [19], which correspond to the import determinants
identified in 5S rRNA, tRK1, H1 RNA, and RMRP (Figure 3). Structural studies permitted to propose
a mechanism by which human PNPase selects RNAs for mitochondrial import [115]. A PNPase
monomer consists of two RNase PH domains (PHI and PHII); a so-called α-helical domain; and two
RNA-binding domains, KH and S1 (Figure 4a). Three monomers assemble into a “doughnut”-shaped
homotrimer with a central channel formed by the six RNase PH domains, where the catalytic site is
located. The KH domains were shown to be important for the single-stranded RNA binding. They form
a “pore” at the entry of the PH channel through which the 3′ end of a single-stranded RNA enters and
subsequently interacts with the catalytic site (Figure 4b) [115]. However, the pore is too narrow to
allow the passage of a structured RNA. A more recent study has proposed that the S1 domains, also
forming a pore atop of the KH domains, interact with structured double-stranded RNAs [113]. If the
length of the 3′ overhang of the bound RNA is too short, it will prevent the entry of the RNA into the
KH pore and the PH channel, protecting it from degradation (Figure 4b) [19,115]. In future studies,
ideally involving mutations that permit to dissociate the ribonuclease and RNA-binding functions
of PNPase would shed light on its actual role in the RNA import pathway and set the stage for the
long-awaited functional analyses of the imported transcripts in the mitochondrial compartment.
Cells 2019, 8, 286 11 of 27
Cells 2019, 8, x FOR PEER REVIEW 11 of 27 
 
pathway and set the stage for the long-awaited functional analyses of the imported transcripts in the 
mitochondrial compartment. 
 
Figure 4. Human polynucleotide phosphorylase as an RNA import factor. (a) Domain organization 
of human PNPase. (b) Schematic model of a PNPase trimer bound to RNA. (Left) If the 3’ overhang 
is long enough, the bound RNA can access the active site (AS) and be degraded. (Right) Structured 
transcripts, e.g., imported small noncoding RNAs cannot enter the KH pore, which prevents their 
degradation [113,115]. 
4. Identification and Validation of Imported RNAs 
Besides the RNA species described above, many other types of small non-coding RNA have been 
detected in human mitochondria, including snRNAs, snoRNAs, piRNAs, and tRNA fragments 
[11,28]. To verify whether those small RNAs are indeed located inside the mitochondria or represent 
mere cytosolic contaminants, adequate experimental techniques are essential, and diverse strategies 
have been proposed to this end. They correspond to five conceptually different methodologies: (1) 
subcellular fractionation and analysis of RNA isolated from RNase-treated mitochondria or 
mitoplasts, (2) in vitro import into isolated mitochondria, (3) microscopy-based approaches, (4) 
compartment-specific tagging techniques, and (5) compartment-specific crosslinking methods. 
4.1. Classical Cellular Fractionation  
Identification of RNA in isolated mitochondria has been the first approach used to discover 
imported RNAs (Figure 5). It relies on isolation of highly pure mitochondria and typically involves 
RNase treatment, which is expected to selectively degrade contaminant RNAs sticking to the 
mitochondrial surface while sparing the transcripts protected by the inner mitochondrial membrane 
in the matrix [116,117]. 
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of human PNPase. (b) Schematic model of a PNPase trimer bound to RNA. (Left) If the 3′ overhang
is long enough, the bound RNA can access the active site (AS) and be degraded. (Right) Structured
transcripts, e.g., imported small noncoding RNAs cannot enter the KH pore, which prevents their
degradation [113,115].
4. Identification and Validation of Imported RNAs
Besides the RNA species described above, many other types of small non-coding RNA have been
detected in human mitochondria, including snRNAs, snoRNAs, piRNAs, and tRNA fragments [11,28].
To verify whether those small RNAs are indeed located inside the mitochondria or represent mere
cytosolic contaminants, adequate experimental techniques are essential, and diverse strategies
have been proposed to this end. They correspond to five conceptually different methodologies:
(1) subcellular fractionation and analysis of RNA isolated from RNase-treated mitochondria or
mitoplasts, (2) in vitro import into isolated mitochondria, (3) microscopy-based approaches, (4)
compartment-specific tagging techniques, and (5) compartment-specific crosslinking methods.
4.1. Classical Cellular Fractionation
Identification of RNA in isolated mitochondria has been the first approach used to discover
imported RNAs (Figure 5). It relies on isolation of highly pure mitochondria and typically involves
RNase treatment, which is expected to selectively degrade contaminant RNAs sticking to the
mitochondrial surface while sparing the transcripts protected by the inner mitochondrial membrane in
the matrix [116,117].
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Figure 5. Analysis of mitochondrial RNA import by subcellular fractionation and in vitro import
assay. Isolated mitochondria can be obtained by cell or tissue homogenization followed by differential
centrifugation (as shown here) or antibody-mediated capture. Crude mitochondria can be used
for in vitro import tests with radiolabeled transcripts or further purified to analyze endogenous
mitochondria-localized RNAs.
4.1.1. Isolation and Purification of Mitochondria
Isolation of mitochondria requires an initial step of cell homogenization in conditions that
maintain mitochondrial integrity, usually followed by differential centrifugations [118]. Low-speed
centrifugation allows for the removal of cellular debris and nuclei while mitochondria remain in
the supernatant. They are then recovered by high-speed centrifugation and typically subjected to
additional purification steps like centrifugation in Percoll gradients or through sucrose cushions to
eliminate light membrane-bounded organelles [119]. Alternatively, mitochondria can be recovered
from disrupted cells with the use of anti-TOM22 antibody-coated magnetic beads [27,31,120], which is
faster and associated with less contamination with cosedimenting organelles, albeit at a cost of a more
modest yield.
In either case, the isolated crude mitochondria remain contaminated with other cellular
components such as the endoplasmic reticulum [121]; Golgi; endosomes; and RNA-containing
organelles such as P-bodies [78], stress granules [122,123], and cytosolic ribosomes engaged in
translation at the surface of OMM [124,125]. To improve the purity of the mitochondrial sample,
the outer membrane is usually removed through the generation of mitoplasts. This can be achieved by
two different approaches: either with detergents such as digitonin, which preferentially permeabilizes
the cholesterol-rich OMM, or by inducing slight swelling of mitochondria and rupture of the outer
mitochondrial membrane by osmotic shock [126,127]. Since the conditions of treatment are always a
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tradeoff between the removal of OMM and the preservation of the integrity of IMM [128], moderate
treatments are preferred, albeit they can only partially destroy the outer membrane in a subpopulation
of mitochondria [127,129]. Mitoplasts are also usually treated with ribonucleases, unable to cross IMM,
to digest remaining cytosolic RNA contaminants. RNA extraction can then be performed to analyze
the mitochondrial RNA composition.
This RNase treatment step is critical as the choice of RNase, and the conditions of digestion
have a direct and decisive impact on the interpretation of the results of the analysis. For instance,
different enzymes have varying specificities and unequal abilities to degrade RNAs, and some types
of transcripts (e.g., miRNAs) are significantly more resistant to RNase-mediated degradation [130] or
extensively protected by associated proteins, making RNase-based methods of little value in assessing
their mitochondrial localization. Identification of such false-positive cases requires special controls
involving the rupture of the mitochondrial membranes with a detergent to prove that the observed
protection was due to the membranes and not to other confounding factors.
4.1.2. Analysis of the Samples
In a hypothesis-driven analysis, when the identities of candidate RNAs are known, northern
blotting and RT-qPCR can be performed to evaluate their presence in the isolated mitoplasts. This is
normally accompanied by quantification of several negative controls (bona fide cytosolic contaminant
RNAs) that should be absent or strongly depleted from the mitoplast preparation.
However, to analyze the mitochondrial RNAs in an unbiased and high-throughput way
and detect potentially new imported transcripts, next-generation sequencing should be opted for.
The experimental design of RNA-seq and the post-analysis pipeline vary greatly in function of the
model system and the biological question. The sequencing of RNA itself may exploit different
methodologies, depending on the library generation protocol and the commercial instrument
used [131]. The diversity of RNA-seq approaches, including size selection steps, facultative rRNA
depletion, differences in equipment, reagents, depth, and sensitivity, may significantly complicate the
comparison of data obtained by different laboratories.
Large-scale analyses of mammalian mitochondrial RNA samples by RNA-seq have been
attempted by many laboratories [11,28,31]. However, in most cases it has remained unclear to what
extent the observed nuclear-encoded RNAs could be imputed to cytosolic contamination. Indeed,
at sufficient depth, RNA-seq provides high detection sensitivity capable to reveal trace amounts of
contaminant RNA, and it appears practically impossible to obtain completely pure mitochondria by
conventional isolation methods. Consequently, the mitochondrial RNome studies published so-far
have been successful in charting the mitochondrial transcriptome [11] but have often been indecisive
and sometimes even contradictory concerning the nuclear-encoded RNAs residing in the organelles.
Obviously, the problem of robust identification of the imported RNAs with RNA-seq cannot be
solved in a naïve “simple detection” mode. Instead, better-controlled enrichment-based approaches
should be adopted. For instance, comparison of transcript levels between mitoplast- and crude
mitochondria-derived RNA samples offer the first simple means to prioritize potentially imported
RNA candidates and dismiss some typical abundant contaminants [11]. Since RNA-seq remains the
only convenient strategy for large-scale analysis of RNomes, further development of robust enrichment
measures and informative controls will be required in order to draw an accurate list of mitochondrially
imported RNAs. It has also become increasingly obvious that the results generated by genome-wide
approaches need to be validated with orthogonal techniques.
4.2. In Vitro RNA Import into Isolated Mitochondria
A simple and popular way to verify the ability of RNA to penetrate into the mitochondria
and at the same time study the biochemical requirements for this process is the in vitro import test
(Figure 5) [116,117]. For this, a radiolabeled RNA transcript of interest is added to isolated crude
mitochondria, eventually in the presence of ATP, ATP-regeneration system and cytosolic protein
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factors. Upon incubation, a ribonuclease treatment is performed to degrade the RNAs outside the
mitochondria, whereas the RNAs in the mitochondrial matrix are protected from degradation by the
mitochondrial membranes. Isolated RNAs are then separated by polyacrylamide gel electrophoresis,
and the presence of the candidate RNA is assessed by autoradiography. It is important to keep in mind
that this approach may only provide proof for the intrinsic ability of RNA to go into the mitochondria,
without guaranteeing that this actually happens in vivo. Therefore, this method has to be combined
with alternative in vivo or in situ approaches.
4.3. Imaging of Mitochondrial RNAs in Intact Cells
Strong evidence of the specific localization of an RNA in mitochondria can be obtained by its direct
observation in cells by fluorescence microscopy. Various approaches have been developed to this end.
The first group of methods is based on the introduction of exogenous RNAs tagged with fluorophores,
fluorogenic aptamers, or protein-binding domains. This can be achieved either by direct transfection of
cells with RNA or by its expression from a plasmid or a stably integrated recombinant gene [132,133].
An immediate advantage of this technique is the possibility to track the motion of recombinant RNA
molecules in live cells. Another group of methods is based on the detection of endogenous RNAs and
does not need introduction of recombinant transcripts. In live cells, endogenous RNAs can be imaged
with the use of designer sequence-specific Pumilio homology domain mutants [134]. Nowadays, the
most popular and reliable technique for direct observation of endogenous RNAs is fluorescence in situ
hybridization (FISH). However, it requires cell fixation, which is incompatible with live cell imaging.
4.3.1. Recombinant RNA Probes
Contrary to some proteins, RNAs cannot produce intrinsic fluorescent signal. Thus, fluorescence
tools that had already been successfully used to study cellular proteins, such as the green fluorescent
protein (GFP), had to be adapted to image RNAs in cells. MS2 tagging was the first system to provide
GFP-mediated imaging of RNA localization [135]. The bacteriophage MS2 coat protein, which can be
fused to GFP, is specifically recruited to a short RNA element consisting of two hairpins (MS2 aptamer)
that can be inserted into RNA of interest. However, unbound GFP results in high background that can
mask specific fluorescent signal. In order to increase the signal-to-noise ratio, multiple repeats of the
MS2 aptamer must be incorporated in RNA, leading to long insertions of hundreds of nucleotides and
potentially affecting the behavior of the tagged transcript [136].
Improvement of the technique was achieved with the development of a series of RNA aptamers
that can capture specific fluorophores and become fluorescent. Unbound fluorophores are poorly
fluorescent and light up only when bound by an RNA aptamer [137,138]. Several aptamers were
successfully developed, including spinach, broccoli, and mango [15,139,140], with each next generation
providing a better affinity for fluorophore, higher fluorescence, and better resistance to photo-bleaching.
The latest improvement in the RNA aptamer-based fluorescent system has allowed for the direct
detection of 5S rRNA in human cells and confirmed its γ-domain-dependent colocalization with
mitochondria [15]. It is important to note that, even though RNA aptamers are relatively small (40 to
100 nt), their presence modifies the structure of the concerned RNA, leading to a potential loss of RNA
function or proper localization, which is particularly relevant for short RNAs. Therefore, detection
of endogenous RNAs looks especially appealing as it permits one to avoid disruption of the RNA
structure and transcript mislocalization.
4.3.2. Imaging of Endogenous RNAs
An original protein-based probe for imaging of endogenous RNAs has been developed on the basis
of Pumilio homology domain (PUM-HD) mutants that have the ability to recognize single-stranded
RNAs in a programmable and modular manner [134]. Ozawa et al. constructed two mitochondrially
targeted Pumilio proteins directed to two eight-base sequences in the mitochondrial MT-ND6 mRNA,
which reconstitute a full-size fluorescent protein upon RNA binding [141]. This approach permitted
Cells 2019, 8, 286 15 of 27
one to monitor the ND6 mRNA dynamics in living mammalian cells. However, using the Pumilio
system requires extensive molecular design, and potential formation of protein dimers or oligomers
may produce false-positive signal.
In a simpler and more straightforward way, detection of specific nucleic acids in the cell can
be performed by fluorescence in situ hybridization (FISH) [142]. In its simplest version, the RNA
molecule of interest is hybridized with a sequence-specific oligonucleotide labeled with a fluorophore.
This technique was employed to detect abundant human mitochondrial transcripts such as the MT-ND6
mRNA and 12S rRNA [63]. The same principle was applied for the visualization of mitochondrial
transcripts in a study addressing the spatio-temporal organization of transcription and replication
in mitochondria [143]. Application of locked nucleic acid (LNA)-modified oligonucleotides made
possible the detection of much less abundant and short microRNAs in human mitochondria [27].
However, the canonical variant of FISH has limited sensitivity since a probe labeled with
only one fluorophore provides a weak signal-over-background ratio. To bypass this limitation and
additionally make the FISH technique truly quantitative, the so-called single-molecule FISH has been
introduced [144]. It is based on the hybridization of multiple fluorescently labeled oligonucleotides
to visualize individual transcripts as diffraction-limited spots. Initially, this approach was almost
exclusively used to detect long transcripts, like mRNAs and ribosomal RNAs, since it requires
hybridization of 20 to 30 oligonucleotides with the length ~20 nt. This limitation has been overcome
by combining FISH with an amplification system. For example, branched DNA technology (bDNA,
Advanced Cell Diagnostics, and Affimetrix) increases the signal-to-background ratio using specific
DNA probes annealing to a target RNA molecule and serving as a platform for subsequent binding of
numerous fluorophore-labelled oligonucleotides [145]. This approach was applied for the detection of
the 11 mitochondrial mRNAs in a high-throughput quantitative image-based transcriptomic study in
human cells [146]. We found that this technology can be adapted for the detection and quantification
of mitochondrially encoded rRNAs, low-abundance non-coding RNAs, and even short transcripts like
tRNAs (Figure 6a).
Despite significant advances in RNA labeling technology, studies of mitochondrial RNA import
by fluorescence microscopy remain a challenging task because of the dual (cytosolic and mitochondrial)
localization of the imported molecules and generally low import efficiency. Furthermore, the very
size of mitochondria borders the resolution limit of the conventional fluorescence microscopy [147].
Thus, it is impossible to clearly distinguish between RNAs located inside the mitochondria and those
simply attached to the mitochondrial surface, as can be seen for the highly abundant 5S rRNA (dual
localized) and 5.8S rRNA (strictly cytosolic) in human cells (Figure 6b). In recent years, due to a
breakthrough in the super-resolution microscopy, it has become possible to achieve a resolution up
to 10 times higher than that imposed by the diffraction limit, allowing for precise sub-organellar
localization of mitochondrial proteins [148–150]. However, very few studies have so-far attempted
to combine RNA smFISH and super-resolution microscopy. One example is an elegant study of the
subcellular distribution and the base-pairing dynamics of an sRNA and an mRNA in E. coli [151].
In contrast, RNA imaging by diffraction-unlimited microscopy in human cells is still an uncharted
area with unclear technical limitations. Super-resolution microscopy holds the promise to answer
some nagging questions about the mitochondrial RNA import and glean important insight into the
functions of nuclear-encoded RNAs within the mitochondria. However, there is still a big road to go
until it will be possible to routinely use this tool in assessing the fine submitochondrial localization of
the imported transcripts.
Cells 2019, 8, 286 16 of 27
Cells 2019, 8, x FOR PEER REVIEW 16 of 27 
 
 
Figure 6. Detection of mitochondrial RNAs in HEK293T-Rex cells by RNA smFISH branched DNA 
and confocal microscopy. (a) mtDNA-derived transcripts: (i) MT-CYTB mRNA, (ii) 12S rRNA, (iii) 
mirror-12S rRNA, and (iv) tRNAVal. RNAs are shown in green (left column), and mitochondria stained 
with antibodies to TOM20 (i–iii) or mL38 (iv) are in magenta (middle column). The right column 
shows merged images. (b) Nuclear-encoded transcripts: (i) 5S rRNA and (ii) 5.8S rRNA. Panel (iii) 
Figure 6. Detection of mitochondrial R s i 293T-Rex cells by RNA smFISH branched DNA
and confocal microscopy. (a) mtDNA-derived transcripts: (i) MT-CYTB mRNA, (ii) 12S rRNA, (iii)
mirror-12S rRNA, and (iv) tRNAVal. RNAs are shown in green (left column), and mitochondria stained
with antibodies to TOM20 (i–iii) or mL38 (iv) are in magenta (middle column). The right column
shows merged images. (b) Nuclear-encoded transcripts: (i) 5S rRNA and (ii) 5.8S rRNA. Panel (iii)
shows TOM20. Panels (iv) and (v) are merged images for 5S rRNA/TOM20 and 5.8S rRNA/TOM20,
respectively. Scale bars are 10 µm.
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4.4. Mitochondria-Specific Tagging of RNAs
A conceptually different group of methods to assess the subcellular localisation of transcripts
builds on in vivo chemical modification of RNAs confined in a membrane-bounded compartment,
such as mitochondrion. This chemical “mark” permits one to specifically enrich and identify modified
RNAs. In a recent embodiment of this principle (Figure 7a), it was proposed to exploit the guanosine
oxidation with singlet oxygen generated by an irradiated fluorescent dye [152,153]. Singlet oxygen
has very short lifetime and, therefore, small diffusion radius, making it an excellent reagent for
proximity labeling. It easily oxidizes nearby guanosines to 8-oxoguanozines, which readily react with
nucleophiles, e.g., propargyl amine. RNAs with guanosines derivatized with propargyl amine can
be specifically labeled in a click reaction with azide-biotin and isolated and analyzed by RT-qPCR
or another method. The compartment-specific localization of fluorescent dye is achieved through
its stable association with a Halo-tag fusion to a protein with the required localization. For instance,
the authors successfully and site-specifically tagged RNAs in the nucleoplasm or nucleoli of human
cells [152,153]. It will be exciting to apply this method to profile mitochondria-localized RNAs,
especially in combination with RNA-seq as detection technique.
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Figure 7. Detection of mitochondrial RNAs with spatially restricted tagging and crosslinking
techniques: (a) spatially restricted guanosine oxidation [152,153], (b) ClickIn [154], (c) APEX-RIP [155]
and Proximity-CLIP [156]. See main text for details.
The recent ClickIn approach exploits an in organello click reaction to verify the uptake of
molecules, such as peptides and peptide nucleic acids, by isolated rat mitochondria [154]. Organelles
pre-loaded with the mitochondria-targeted cyclooctyne MitoOct are incubated with an azide-labeled
substrate (Figure 7b). If the molecule is internalized by the mitochondria, a click reaction takes place
and the resulting adduct can be detected by mass spectrometry. Although this method is currently
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available only for isolated mitochondria, it may provide an excellent alternative to RNase-based
approaches in assessing the mitochondrial import of short transcripts, such as miRNAs.
4.5. Spatially Restricted Crosslinking-Based Techniques
A methodologically similar group of approaches is based on compartment-specific crosslinking of
RNAs to proteins for their subsequent isolation and identification. Two slightly different variations of
this method have been published so-far: APEX-RIP [155] and Proximity-CLIP [156] (Figure 7c). In both
cases, ascorbate peroxidase (APEX) is targeted to the subcellular location of interest where it catalyzes
the oxidation of biotin-phenol by hydrogen peroxide. The resulting biotin-phenoxyl radicals are
extremely short-lived and covalently modify nearby proteins in a radius of <5 nm. This enables their
subsequent isolation on streptavidin beads, and identification by mass spectrometry, which has been
successfully used to profile the human mitochondrial proteome with an exquisite spatial resolution
permitting to distinguish matrix- and IMS-localized proteins [157]. To expand the scope of this
method to RNAs, APEX-RIP introduced a formaldehyde crosslinking step, whereas Proximity-CLIP
relies on UV crosslinking to covalently attach RNAs to neighboring proteins [155,156]. The RNAs
co-purified with biotinylated proteins under stringent conditions and became significantly enriched in
comparison to negative control IPs (e.g., without crosslinking or biotin-phenol or hydrogen peroxide),
which are considered bona fide residents in the analyzed compartment. For instance, by using a
mitochondrially targeted mito-APEX2 protein, the APEX-RIP technique has recently permitted one
to profile mitochondrial RNAs in HEK293T cells [155]. Interestingly, the authors did not detect any
long nuclear-encoded RNAs, while they readily identified all long mitochondria-encoded transcripts.
The method, however, remains to be applied to small RNAs, as they constitute the majority of the
RNAs identified or suggested to be imported into mitochondria.
5. Unsolved Questions and Future Directions
Although the history of research in mitochondrial RNA import counts now four decades, many
nagging questions persist. How do the RNAs destined for mitochondria get selected from the cellular
milieu and transported to the mitochondrial surface? Does this process differ between cell types and
metabolic conditions? How do RNAs cross the inner mitochondrial membrane? Where are they located
inside the organelles and, most importantly, what do they do there? With the recent development of
microscopy and other in situ methods and interactomic and molecular biology approaches, it seems
that the long-awaited methodology is coming of age to tackle these problems in a more conclusive way.
Our knowledge of the spatial organization of the RNA metabolism in human cells has experienced
a qualitative breakthrough over the last few years [158,159]. Characteristic markers of various
submitochondrial locations have been identified, and their associated functions are finally coming to
light, meaning that unique insights into the role of mitochondria-localized transcripts could be gained
from combined studies of their interactions with RNA-binding proteins [160], genetic approaches, and
fine-scale microscopy analyses (e.g., expansion microscopy [161] and super-resolution techniques).
The question of which nuclear-encoded RNAs are imported in mammalian mitochondria is a
matter of controversy, and some speculative arguments (e.g., inability of imported RNA species to
perform their canonical functions in the mitochondrial compartment) have been forwarded [162].
Taking into account that alternative RNA functions are a widespread phenomenon (consider, for
example, the multiple roles of tRNA [163]), such considerations certainly do not permit to rule out
the existence of mitochondria-localized pools of select cytosolic RNAs. Moreover, one cannot exclude
that many of the imported RNAs do not have any function (yet) and simply represent evolutionary
material, which may, in distant future, contribute to a progressive replacement of lost mitochondrial
genes, as happened in other eukaryotic lineages. We believe that only solid experimentation relying
on a combination of several orthogonal approaches can provide a decisive answer to the question of
which RNAs are delivered into the mitochondria and which are not. In this regard, recent in situ and
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in vivo techniques, including APEX-RIP and spatially restricted tagging approaches, which do not
require subcellular fractionation and RNase treatment, are particularly promising.
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